The utility of a composite endpoint for tracking disease progression in Lewy body dementia

Abstract INTRODUCTION Dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD), collectively termed Lewy body dementia (LBD), show heterogenous progression across cognitive, motor, and neuropsychiatric symptom domains, yet disease‐specific endpoints are lacking. We evaluated whether a c...

Description complète

Détails bibliographiques

Auteurs principaux:	Elie Matar, Simon R. White, John‐Paul Taylor, Alan Thomas, Ian McKeith, Joseph Kane, Simon Lewis, Ajenthan Surendranathan, John O'Brien
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2026-04-01
Collection:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Sujets:	caregiver burden clinical trials composite endpoints disease progression Lewy body dementia multidomain assessment
Accès en ligne:	https://doi.org/10.1002/trc2.70260
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!